Gillinder Bedi
Cited by
Cited by
Automated analysis of free speech predicts psychosis onset in high-risk youths
G Bedi, F Carrillo, GA Cecchi, DF Slezak, M Sigman, NB Mota, S Ribeiro, ...
npj Schizophrenia 1 (1), 1-7, 2015
Prediction of psychosis across protocols and risk cohorts using automated language analysis
CM Corcoran, F Carrillo, D Fernández‐Slezak, G Bedi, C Klim, DC Javitt, ...
World Psychiatry 17 (1), 67-75, 2018
Is ecstasy an “empathogen”? Effects of±3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others
G Bedi, D Hyman, H de Wit
Biological psychiatry 68 (12), 1134-1140, 2010
Incubation of cue-induced cigarette craving during abstinence in human smokers
G Bedi, KL Preston, DH Epstein, SJ Heishman, GF Marrone, Y Shaham, ...
Biological psychiatry 69 (7), 708-711, 2011
Effects of MDMA on sociability and neural response to social threat and social reward
G Bedi, KL Phan, M Angstadt, H De Wit
Psychopharmacology 207, 73-83, 2009
Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis
M Haney, RJ Malcolm, S Babalonis, PA Nuzzo, ZD Cooper, G Bedi, ...
Neuropsychopharmacology 41 (8), 1974-1982, 2016
Intimate partner violence: What are the impacts on children?
G Bedi, C Goddard
Australian Psychologist 42 (1), 66-77, 2007
The prosocial effects of 3, 4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals
P Kamilar-Britt, G Bedi
Neuroscience & Biobehavioral Reviews 57, 433-446, 2015
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability
ZD Cooper, G Bedi, D Ramesh, R Balter, SD Comer, M Haney
Neuropsychopharmacology 43 (10), 2046-2055, 2018
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse
M Haney, ZD Cooper, G Bedi, SK Vosburg, SD Comer, RW Foltin
Neuropsychopharmacology 38 (8), 1557-1565, 2013
Optimism, coping style and emotional well‐being in cardiac patients
G Bedi, SL Brown
British journal of health psychology 10 (1), 57-70, 2005
A window into the intoxicated mind? Speech as an index of psychoactive drug effects
G Bedi, GA Cecchi, DF Slezak, F Carrillo, M Sigman, H De Wit
Neuropsychopharmacology 39 (10), 2340-2348, 2014
Subjective, cognitive and cardiovascular dose‐effect profile of nabilone and dronabinol in marijuana smokers
G Bedi, ZD Cooper, M Haney
Addiction biology 18 (5), 872-881, 2013
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status
M Haney, G Bedi, ZD Cooper, A Glass, SK Vosburg, SD Comer, RW Foltin
Biological psychiatry 73 (3), 242-248, 2013
Intimate partner violence and child abuse: a child‐centred perspective
C Goddard, G Bedi
Child Abuse Review: Journal of the British Association for the Study and …, 2010
Gender inequality in awarded research grants
G Bedi, NT Van Dam, M Munafo
The Lancet 380 (9840), 474, 2012
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
G Bedi, RW Foltin, EW Gunderson, J Rabkin, CL Hart, SD Comer, ...
Psychopharmacology 212, 675-686, 2010
Impact of social status and antidepressant treatment on neurogenesis in the baboon hippocampus
MV Wu, JL Shamy, G Bedi, CWJ Choi, MM Wall, V Arango, M Boldrini, ...
Neuropsychopharmacology 39 (8), 1861-1871, 2014
Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers
M Haney, D Ramesh, A Glass, M Pavlicova, G Bedi, ZD Cooper
Neuropsychopharmacology 40 (11), 2489-2498, 2015
Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds
G Bedi, J Redman
Psychological medicine 38 (9), 1319-1330, 2008
The system can't perform the operation now. Try again later.
Articles 1–20